Home > Market Activity > Get Quotes > Company Information

Aurinia Pharmaceuticals Inc.

Exchange: TSX Exchange | Jun 21, 2018, 6:08 AM EDT

AUP
$ 8.05 real time data Change Up
Change:
0.09 (1.13%)
Volume:
36,421
Real-time price
Day Low 7.93
Day High 8.16


Company Profile for Aurinia Pharmaceuticals Inc.

Description & Contact Information
Business Description: Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The firm is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.
Address: 4464 Markham Street, Suite 1203, Victoria, BC, CAN, V8Z 7X8
Telephone: +1 250 744-2487 Website: http://www.auriniapharma.com
Facsimile: +1 250 744-2498 Email: ir@auriniapharma.com
Fiscal Year End: 12/2017
Industry Classifications
Sector: Healthcare CIK: 1600620
Industry: Biotechnology SIC: 3741
NAICS: Pharmaceutical Preparation Manufacturing (325412)
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges.
Market Data powered by QuoteMedia, Profiles by Morningstar. See the QuoteMedia Terms of Use.